August 11, 2020 -- Romark has initiated a phase III clinical trial of its investigational new drug candidate Nt-300 (nitazoxanide extended-release tablets) as a treatment for mild or moderate COVID-19.
August 10, 2020 -- Novocellbio has confirmed that its autologous natural killer cell treatment agent is effective in killing SARS-CoV-2.
August 6, 2020 -- Contract research organizations (CROs) Caprion-HistoGeneX and Viroclinics have formed a strategic partnership to develop therapeutics and prophylactic solutions targeting infectious diseases like COVID-19.
August 5, 2020 -- Kriya Therapeutics has secured a 51,000-sq-ft facility in Research Triangle Park, NC, to establish internal operational manufacturing of its pipeline of adeno-associated virus-based gene therapies.
August 4, 2020 -- Twist Bioscience and Seismic Bio have formed a partnership to discover and optimize antibodies to high-value immuno-oncology targets.
July 31, 2020 -- Immunoprecise Antibodies has conducted additional characterization of a subset of fully human, therapeutic SARS-CoV-2 antibodies that are potent and exhibit enhanced neutralization upon combinatorial testing.
July 31, 2020 -- Clinical-stage biopharmaceutical company Enterome has begun its first clinical trial for E02401, a microbiome-based cancer immunotherapy candidate.
July 30, 2020 -- Regenerative medical products manufacturer Direct Biologics has won approval from the U.S. Food and Drug Administration to study its ExoFlo therapy in a clinical trial with COVID-19 patients.
July 30, 2020 -- SAB Biotherapeutics has begun a phase I clinical trial evaluating SAB-176 for the treatment of seasonal influenza.
July 29, 2020 -- Vaccine development firm Intravacc and biopharmaceutical contract development and manufacturing organization Celonic are teaming up to develop a COVID-19 vaccine.
Conferences
ACS Fall 2020 Virtual Meeting & Expo
August 17-20
August 17-20
ESMO Virtual Congress 2020
September 14-29
September 14-29
2020 ACCP Annual Meeting
September 20-22
Bethesda, Maryland United States
September 20-22
Bethesda, Maryland United States
Bioprocess International West
September 21-24
Eastern Standard Time Zone (EST) United States
September 21-24
Eastern Standard Time Zone (EST) United States
BioProcess International
September 21-24
Eastern Standard Time Zone (EST), Massachusetts United States
September 21-24
Eastern Standard Time Zone (EST), Massachusetts United States
|
General Discussion
|
||
| Topic | Replies / Views | Last Update |
|---|---|---|
|
Childhood vaccines may help protect against COVID-19 mortality
|
0 / 6 | More than 3 days ago |
|
https://academic.oup.com/ve/pages/coronavirus-evolution
|
0 / 49 | More than 3 days ago |
|
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
|
0 / 14 | More than 3 days ago |
|
Engineered Bacteria Produces BeeFree Honey
|
0 / 13 | More than 3 days ago |
|
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
|
0 / 15 | More than 3 days ago |
| To see more posts from our community or to share a post of your own, go to our community's forum page. | ||
Insights
Exclusive content for Science Advisory Board members on trends and outcomes that are influencing the future of scientific research.
Communities
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Rewards
Earn points for contributing to research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Connect
